{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:41:35Z","timestamp":1792784495514,"version":"4.5.0"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministero italiano della Salute e PRIN 2020 MIUR","award":["2020FYCCE3"],"award-info":[{"award-number":["2020FYCCE3"]}]},{"name":"Universit\u00e0 degli Studi di Roma La Sapienza","id":[{"id":"https:\/\/ror.org\/02be6w209","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Tall stature is defined as height greater than the threshold of more than 2 standard deviations above the average population height for age, sex, and ethnicity. Many studies have described the main aspects of this condition during puberty, but an analysis of the characteristics that the physician should consider in the differential diagnosis of gigantism\u2014tall stature secondary to a pituitary tumour\u2014during the transition age (15\u201325\u00a0years) is still lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive search of English-language original articles was conducted in the MEDLINE database (December 2021-March 2022). We selected all studies regarding epidemiology, genetic aspects, and the diagnosis of tall stature and gigantism during the transition age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Generally, referrals for tall stature are not as frequent as expected because most cases are familial and are usually unreported by parents and patients to endocrinologists. For this reason, lacking such experience of tall stature, familiarity with many rarer overgrowth syndromes is essential. In the transition age, it is important but challenging to distinguish adolescents with high constitutional stature from those with gigantism. Pituitary gigantism is a rare disease in the transition age, but its systemic complications are very relevant for future health. Endocrine evaluation is crucial for identifying conditions that require hormonal treatment so that they can be treated early to improve the quality of life and prevent comorbidities of individual patient in this age range.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The aim of our review is to provide a practical clinical approach to recognise adolescents, potentially affected by gigantism, as early as possible.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40618-023-02223-z","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T12:01:44Z","timestamp":1698408104000},"page":"777-793","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Tall stature and gigantism in transition\u00a0age: clinical and genetic aspects\u2014a literature review and recommendations"],"prefix":"10.1007","volume":"47","author":[{"given":"V.","family":"Sada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Puliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Feola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pirchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"De Alcubierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. E.","family":"Amodeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"D\u2019Aniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vincenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gianfrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Isidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. B.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2220-9783","authenticated-orcid":false,"given":"E.","family":"Sbardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the TALENT group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Foresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Durante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"De Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Paoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ferrigno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Caiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Minnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Hasenmajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Cangiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tenuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Carlomagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Di Nisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pallotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Tarsitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Spaziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cargnelutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Sabovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Grani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Virili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Stramazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Filardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"issue":"1","key":"2223_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13052-017-0385-5","volume":"43","author":"C Meazza","year":"2017","unstructured":"Meazza C et al (2017) Tall stature: a difficult diagnosis? Ital J Pediatr 43(1):66","journal-title":"Ital J Pediatr"},{"key":"2223_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jpeds.2016.02.068","volume":"173","author":"YH Jee","year":"2016","unstructured":"Jee YH, Baron J (2016) The biology of stature. J Pediatr 173:32\u201338","journal-title":"J Pediatr"},{"issue":"12","key":"2223_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrendo.2015.165","volume":"11","author":"J Baron","year":"2015","unstructured":"Baron J et al (2015) Short and tall stature: a new paradigm emerges. Nat Rev Endocrinol 11(12):735\u2013746","journal-title":"Nat Rev Endocrinol"},{"key":"2223_CR4","unstructured":"Camacho-Hubner C (2000) Normal Physiology of Growth Hormone and Insulin-Like Growth Factors in Childhood, in Endotext, K.R. Feingold, et al., Editors. South Dartmouth (MA)"},{"issue":"2","key":"2223_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/cen.13232","volume":"86","author":"E Sbardella","year":"2017","unstructured":"Sbardella E et al (2017) Baseline morning cortisol level as a predictor of pituitary-adrenal reserve: a comparison across three assays. Clin Endocrinol 86(2):177\u2013184","journal-title":"Clin Endocrinol"},{"issue":"1","key":"2223_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2174\/1573396314666181105092917","volume":"15","author":"B Corredor","year":"2019","unstructured":"Corredor B et al (2019) Tall stature: a challenge for clinicians. Curr Pediatr Rev 15(1):10\u201321","journal-title":"Curr Pediatr Rev"},{"issue":"4","key":"2223_CR7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s11102-020-01052-0","volume":"23","author":"E Sbardella","year":"2020","unstructured":"Sbardella E et al (2020) GH deficiency in cancer survivors in the transition age: diagnosis and therapy. Pituitary 23(4):432\u2013456","journal-title":"Pituitary"},{"key":"2223_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.yapd.2019.04.004","volume":"66","author":"AKC Leung","year":"2019","unstructured":"Leung AKC, Leung AAC, Hon KL (2019) Tall stature in children. Adv Pediatr 66:161\u2013176","journal-title":"Adv Pediatr"},{"issue":"6","key":"2223_CR9","doi-asserted-by":"publisher","first-page":"R339","DOI":"10.1530\/EJE-16-1054","volume":"176","author":"EVA Albuquerque","year":"2017","unstructured":"Albuquerque EVA, Scalco RC, Jorge AAL (2017) MANAGEMENT OF ENDOCRINE DISEASE: diagnostic and therapeutic approach of tall stature. Eur J Endocrinol 176(6):R339\u2013R353","journal-title":"Eur J Endocrinol"},{"issue":"2\u20133","key":"2223_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jad.2005.11.019","volume":"91","author":"FJ Bruinsma","year":"2006","unstructured":"Bruinsma FJ et al (2006) Concern about tall stature during adolescence and depression in later life. J Affect Disord 91(2\u20133):145\u2013152","journal-title":"J Affect Disord"},{"issue":"4","key":"2223_CR11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4274\/jcrpe.2220","volume":"7","author":"SE Stalman","year":"2015","unstructured":"Stalman SE et al (2015) Diagnostic work-up and follow-up in children with tall stature: a simplified algorithm for clinical practice. J Clin Res Pediatr Endocrinol 7(4):260\u2013267","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"12","key":"2223_CR12","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1542\/pir.35.12.538","volume":"35","author":"S Zargham","year":"2014","unstructured":"Zargham S, Crotty JE (2014) Tall stature. Pediatr Rev 35(12):538\u2013539 (discussion 539)","journal-title":"Pediatr Rev"},{"issue":"1","key":"2223_CR13","first-page":"43","volume":"92","author":"C Barstow","year":"2015","unstructured":"Barstow C, Rerucha C (2015) Evaluation of short and tall stature in children. Am Fam Physician 92(1):43\u201350","journal-title":"Am Fam Physician"},{"issue":"2","key":"2223_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ando.2017.04.006","volume":"78","author":"R Coutant","year":"2017","unstructured":"Coutant R et al (2017) How to investigate a child with excessive growth? Ann Endocrinol 78(2):98\u2013103","journal-title":"Ann Endocrinol"},{"issue":"6","key":"2223_CR15","first-page":"563","volume":"55","author":"L Iughetti","year":"2003","unstructured":"Iughetti L, Bergomi A, Bernasconi S (2003) Diagnostic approach and therapy of overgrowth and tall stature in childhood. Minerva Pediatr 55(6):563\u2013582","journal-title":"Minerva Pediatr"},{"issue":"3","key":"2223_CR16","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/sj.ejhg.5201686","volume":"15","author":"K Tatton-Brown","year":"2007","unstructured":"Tatton-Brown K, Rahman N (2007) Sotos syndrome. Eur J Hum Genet 15(3):264\u2013271","journal-title":"Eur J Hum Genet"},{"key":"2223_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.574857","volume":"8","author":"J Manor","year":"2020","unstructured":"Manor J, Lalani SR (2020) Overgrowth syndromes-evaluation, diagnosis, and management. Front Pediatr 8:574857","journal-title":"Front Pediatr"},{"issue":"5","key":"2223_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000500810","volume":"91","author":"P Lauffer","year":"2019","unstructured":"Lauffer P et al (2019) Towards a rational and efficient diagnostic approach in children referred for tall stature and\/or accelerated growth to the general paediatrician. Horm Res Paediatr 91(5):293\u2013310","journal-title":"Horm Res Paediatr"},{"issue":"7","key":"2223_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1177\/0009922807311740","volume":"47","author":"V Narayanaswamy","year":"2008","unstructured":"Narayanaswamy V, Rettig KR, Bhowmick SK (2008) Excessive growth. Clin Pediatr 47(7):705\u2013708","journal-title":"Clin Pediatr"},{"issue":"3","key":"2223_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF03344942","volume":"16","author":"J Etxabe","year":"1993","unstructured":"Etxabe J et al (1993) Acromegaly: an epidemiological study. J Endocrinol Invest 16(3):181\u2013187","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2223_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/MED.0000000000000212","volume":"23","author":"MB Lodish","year":"2016","unstructured":"Lodish MB, Trivellin G, Stratakis CA (2016) Pituitary gigantism: update on molecular biology and management. Curr Opin Endocrinol Diabetes Obes 23(1):72\u201380","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2223_CR22","unstructured":"George, M.M., E.A. Eugster, and S.D. Chernausek, Pituitary Gigantism, in Endotext, K.R. Feingold, et al., Editors. 2000: South Dartmouth (MA)."},{"issue":"1","key":"2223_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003735","volume":"4","author":"V Natale","year":"2014","unstructured":"Natale V, Rajagopalan A (2014) Worldwide variation in human growth and the World Health Organization growth standards: a systematic review. BMJ Open 4(1):e003735","journal-title":"BMJ Open"},{"issue":"9","key":"2223_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2471\/BLT.07.043497","volume":"85","author":"M de Onis","year":"2007","unstructured":"de Onis M et al (2007) Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 85(9):660\u2013667","journal-title":"Bull World Health Organ"},{"issue":"5","key":"2223_CR25","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/cen.14067","volume":"91","author":"M Herath","year":"2019","unstructured":"Herath M et al (2019) Paediatric and young adult manifestations and outcomes of multiple endocrine neoplasia type 1. Clin Endocrinol 91(5):633\u2013638","journal-title":"Clin Endocrinol"},{"key":"2223_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.111094","volume":"520","author":"M Spaziani","year":"2021","unstructured":"Spaziani M et al (2021) Hypothalamo-pituitary axis and puberty. Mol Cell Endocrinol 520:111094","journal-title":"Mol Cell Endocrinol"},{"issue":"239","key":"2223_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/adc.45.239.13","volume":"45","author":"WA Marshall","year":"1970","unstructured":"Marshall WA, Tanner JM (1970) Variations in the pattern of pubertal changes in boys. Arch Dis Child 45(239):13\u201323","journal-title":"Arch Dis Child"},{"issue":"8","key":"2223_CR28","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1136\/archdischild-2013-304830","volume":"99","author":"JH Davies","year":"2014","unstructured":"Davies JH, Cheetham T (2014) Investigation and management of tall stature. Arch Dis Child 99(8):772\u2013777","journal-title":"Arch Dis Child"},{"issue":"1","key":"2223_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41390-020-01215-6","volume":"90","author":"EN Upners","year":"2021","unstructured":"Upners EN et al (2021) Does height and IGF-I determine pubertal timing in girls? Pediatr Res 90(1):176\u2013183","journal-title":"Pediatr Res"},{"issue":"2","key":"2223_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/humupd\/dmh012","volume":"10","author":"JC Carel","year":"2004","unstructured":"Carel JC et al (2004) Precocious puberty and statural growth. Hum Reprod Update 10(2):135\u2013147","journal-title":"Hum Reprod Update"},{"issue":"4","key":"2223_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s40272-015-0130-8","volume":"17","author":"M Chen","year":"2015","unstructured":"Chen M, Eugster EA (2015) Central precocious puberty: update on diagnosis and treatment. Paediatr Drugs 17(4):273\u2013281","journal-title":"Paediatr Drugs"},{"issue":"4","key":"2223_CR32","doi-asserted-by":"publisher","first-page":"R155","DOI":"10.1530\/EJE-19-0298","volume":"181","author":"E Sbardella","year":"2019","unstructured":"Sbardella E et al (2019) ENDOCRINOLOGY AND ADOLESCENCE: dealing with transition in young patients with pituitary disorders. Eur J Endocrinol 181(4):R155\u2013R171","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2223_CR33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s12887-021-02936-1","volume":"21","author":"G Liu","year":"2021","unstructured":"Liu G et al (2021) Obesity is a risk factor for central precocious puberty: a case-control study. BMC Pediatr 21(1):509","journal-title":"BMC Pediatr"},{"key":"2223_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.672394","volume":"12","author":"X Zhai","year":"2021","unstructured":"Zhai X et al (2021) Clinical characteristics and management of patients with mccune-albright syndrome with GH excess and precocious puberty: a case series and literature review. Front Endocrinol 12:672394","journal-title":"Front Endocrinol"},{"issue":"6 Pt 1","key":"2223_CR35","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1542\/peds.103.6.1257","volume":"103","author":"D Carmi","year":"1999","unstructured":"Carmi D et al (1999) Growth, puberty, and endocrine functions in patients with sporadic or familial neurofibromatosis type 1: a longitudinal study. Pediatrics 103(6 Pt 1):1257\u20131262","journal-title":"Pediatrics"},{"issue":"1","key":"2223_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ajmg.c.31349","volume":"163C","author":"L Aksglaede","year":"2013","unstructured":"Aksglaede L et al (2013) 47, XXY Klinefelter syndrome: clinical characteristics and age-specific recommendations for medical management. Am J Med Genet C Semin Med Genet 163C(1):55\u201363","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"12","key":"2223_CR37","doi-asserted-by":"publisher","first-page":"e247989","DOI":"10.1136\/bcr-2021-247989","volume":"14","author":"C Cunha","year":"2021","unstructured":"Cunha C et al (2021) Successful treatment of pituitary gigantism. BMJ Case Rep 14(12):e247989","journal-title":"BMJ Case Rep"},{"key":"2223_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jpeds.2020.09.007","volume":"228","author":"BY Rollins","year":"2021","unstructured":"Rollins BY, Francis LA (2021) Off the charts: identifying and visualizing body mass index trajectories of rural, poor youth. J Pediatr 228:147\u20131542","journal-title":"J Pediatr"},{"issue":"5","key":"2223_CR39","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1530\/ERC-15-0320","volume":"22","author":"L Rostomyan","year":"2015","unstructured":"Rostomyan L et al (2015) Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. Endocr Relat Cancer 22(5):745\u2013757","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"2223_CR40","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.metabol.2005.03.025","volume":"54","author":"M Bondanelli","year":"2005","unstructured":"Bondanelli M et al (2005) Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism. Metabolism 54(9):1174\u20131180","journal-title":"Metabolism"},{"issue":"5","key":"2223_CR41","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/j.1365-2265.2007.02809.x","volume":"66","author":"A Colao","year":"2007","unstructured":"Colao A et al (2007) Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome. Clin Endocrinol 66(5):714\u2013722","journal-title":"Clin Endocrinol"},{"issue":"1","key":"2223_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40618-022-01900-9","volume":"46","author":"T Feola","year":"2023","unstructured":"Feola T et al (2023) Sellar and parasellar lesions in the transition age: a retrospective Italian multi-centre study. J Endocrinol Invest 46(1):181\u2013188","journal-title":"J Endocrinol Invest"},{"issue":"220","key":"2223_CR43","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/adc.41.220.613","volume":"41","author":"JM Tanner","year":"1966","unstructured":"Tanner JM, Whitehouse RH, Takaishi M (1966) Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II Arch Dis Child 41(220):613\u2013635","journal-title":"II Arch Dis Child"},{"issue":"3","key":"2223_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4274\/jcrpe.galenos.2020.2020.0091","volume":"13","author":"M Prokop-Piotrkowska","year":"2021","unstructured":"Prokop-Piotrkowska M et al (2021) Traditional and new methods of bone age assessment-an overview. J Clin Res Pediatr Endocrinol 13(3):251\u2013262","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"6556","key":"2223_CR45","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/bmj.293.6556.1186","volume":"293","author":"CG Brook","year":"1986","unstructured":"Brook CG, Hindmarsh PC, Healy MJ (1986) A better way to detect growth failure. Br Med J Clin Res Ed 293(6556):1186","journal-title":"Br Med J Clin Res Ed"},{"issue":"4","key":"2223_CR46","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1515\/jpem-2016-0355","volume":"30","author":"S Pagani","year":"2017","unstructured":"Pagani S et al (2017) Analysis of growth hormone receptor gene expression in tall and short stature children. J Pediatr Endocrinol Metab 30(4):427\u2013430","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"2223_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1515\/JPEM.2005.18.2.165","volume":"18","author":"O Butenandt","year":"2005","unstructured":"Butenandt O, Bechtold S, Meidert A (2005) Final height in patients with constitutional delay of growth and development from tall statured families. J Pediatr Endocrinol Metab 18(2):165\u2013169","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"2223_CR48","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/ajmg.10312","volume":"109","author":"G Erkula","year":"2002","unstructured":"Erkula G et al (2002) Growth and maturation in Marfan syndrome. Am J Med Genet 109(2):100\u2013115","journal-title":"Am J Med Genet"},{"issue":"7","key":"2223_CR49","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3346\/jkms.2015.30.7.911","volume":"30","author":"Y Kwun","year":"2015","unstructured":"Kwun Y et al (2015) Disease-specific growth charts of Marfan syndrome patients in Korea. J Korean Med Sci 30(7):911\u2013916","journal-title":"J Korean Med Sci"},{"issue":"1\u20131","key":"2223_CR50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/pr.2017.210","volume":"83","author":"G Benoist","year":"2018","unstructured":"Benoist G et al (2018) Skeletal evolution in Marfan syndrome: growth curves from a French national cohort. Pediatr Res 83(1\u20131):71\u201377","journal-title":"Pediatr Res"},{"issue":"25","key":"2223_CR51","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1161\/CIRCULATIONAHA.109.887042","volume":"120","author":"D Attias","year":"2009","unstructured":"Attias D et al (2009) Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation 120(25):2541\u20132549","journal-title":"Circulation"},{"issue":"2","key":"2223_CR52","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.arcped.2017.12.010","volume":"25","author":"J Vergier","year":"2018","unstructured":"Vergier J et al (2018) Investigation of tall stature in children: diagnostic work-up, review of the main causes. Arch Pediatr 25(2):163\u2013169","journal-title":"Arch Pediatr"},{"issue":"7","key":"2223_CR53","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/jcm10071377","volume":"10","author":"A Boguslawska","year":"2021","unstructured":"Boguslawska A, Korbonits M (2021) Genetics of acromegaly and gigantism. J Clin Med 10(7):1377","journal-title":"J Clin Med"},{"issue":"2","key":"2223_CR54","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1210\/er.2012-1013","volume":"34","author":"A Beckers","year":"2013","unstructured":"Beckers A et al (2013) Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev 34(2):239\u2013277","journal-title":"Endocr Rev"},{"issue":"11","key":"2223_CR55","doi-asserted-by":"publisher","first-page":"E373","DOI":"10.1210\/jc.2009-2556","volume":"95","author":"AF Daly","year":"2010","unstructured":"Daly AF et al (2010) Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab 95(11):E373\u2013E383","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2223_CR56","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/humu.21292","volume":"31","author":"S Igreja","year":"2010","unstructured":"Igreja S et al (2010) Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Hum Mutat 31(8):950\u2013960","journal-title":"Hum Mutat"},{"issue":"4","key":"2223_CR57","doi-asserted-by":"publisher","first-page":"E663","DOI":"10.1210\/jc.2011-2291","volume":"97","author":"L Cazabat","year":"2012","unstructured":"Cazabat L et al (2012) Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients. J Clin Endocrinol Metab 97(4):E663\u2013E670","journal-title":"J Clin Endocrinol Metab"},{"key":"2223_CR58","doi-asserted-by":"publisher","DOI":"10.1530\/ey.17.1.10","author":"P Marques","year":"2020","unstructured":"Marques P et al (2020) Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1530\/ey.17.1.10","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2223_CR59","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1530\/EJE-11-0304","volume":"165","author":"MA Tichomirowa","year":"2011","unstructured":"Tichomirowa MA et al (2011) High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. Eur J Endocrinol 165(4):509\u2013515","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2223_CR60","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/EJE-12-0763","volume":"168","author":"T Cuny","year":"2013","unstructured":"Cuny T et al (2013) Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don\u2019t forget MEN1 genetic analysis. Eur J Endocrinol 168(4):533\u2013541","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2223_CR61","doi-asserted-by":"publisher","first-page":"E1242","DOI":"10.1210\/jc.2015-1869","volume":"100","author":"LC Hernandez-Ramirez","year":"2015","unstructured":"Hernandez-Ramirez LC et al (2015) Landscape of familial isolated and young-onset pituitary adenomas: prospective diagnosis in AIP mutation carriers. J Clin Endocrinol Metab 100(9):E1242\u2013E1254","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2223_CR62","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s11102-020-01105-4","volume":"24","author":"EB Trarbach","year":"2021","unstructured":"Trarbach EB et al (2021) Genetics, clinical features and outcomes of non-syndromic pituitary gigantism: experience of a single center from Sao Paulo. Brazil Pituitary 24(2):252\u2013261","journal-title":"Brazil Pituitary"},{"issue":"8","key":"2223_CR63","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1210\/jc.2019-00432","volume":"104","author":"P Dutta","year":"2019","unstructured":"Dutta P et al (2019) Surgery, octreotide, temozolomide, bevacizumab, radiotherapy, and pegvisomant treatment of an AIP mutation positive child. J Clin Endocrinol Metab 104(8):3539\u20133544","journal-title":"J Clin Endocrinol Metab"},{"key":"2223_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1166076","author":"G Trivellin","year":"2023","unstructured":"Trivellin G et al (2023) Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion. medRxiv. https:\/\/doi.org\/10.3389\/fendo.2023.1166076","journal-title":"medRxiv"},{"issue":"9","key":"2223_CR65","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV et al (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97(9):2990\u20133011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2223_CR66","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/humu.20605","volume":"29","author":"MC Lemos","year":"2008","unstructured":"Lemos MC, Thakker RV (2008) Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29(1):22\u201332","journal-title":"Hum Mutat"},{"issue":"1\u20132","key":"2223_CR67","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cancergen.2015.12.002","volume":"209","author":"P Concolino","year":"2016","unstructured":"Concolino P, Costella A, Capoluongo E (2016) Multiple endocrine neoplasia type 1 (MEN1): an update of 208 new germline variants reported in the last nine years. Cancer Genet 209(1\u20132):36\u201341","journal-title":"Cancer Genet"},{"issue":"19\u201320","key":"2223_CR68","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s00508-007-0883-3","volume":"119","author":"DK Bartsch","year":"2007","unstructured":"Bartsch DK, Langer P, Rothmund M (2007) Surgical aspects of gastrinoma in multiple endocrine neoplasia type 1. Wien Klin Wochenschr 119(19\u201320):602\u2013608","journal-title":"Wien Klin Wochenschr"},{"key":"2223_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000345666","volume":"41","author":"SK Agarwal","year":"2013","unstructured":"Agarwal SK (2013) Multiple endocrine neoplasia type 1. Front Horm Res 41:1\u201315","journal-title":"Front Horm Res"},{"key":"2223_CR70","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fendo.2019.00339","volume":"10","author":"CDC Kamilaris","year":"2019","unstructured":"Kamilaris CDC, Stratakis CA (2019) Multiple endocrine neoplasia type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis. Front Endocrinol 10:339","journal-title":"Front Endocrinol"},{"key":"2223_CR71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.12688\/f1000research.7230.1","volume":"6","author":"A Falchetti","year":"2017","unstructured":"Falchetti A (2017) Genetics of multiple endocrine neoplasia type 1 syndrome: what\u2019s new and what\u2019s old. F100Res 6:73","journal-title":"F100Res"},{"issue":"Suppl 1","key":"2223_CR72","doi-asserted-by":"publisher","first-page":"43","DOI":"10.6061\/clinics\/2012(Sup01)09","volume":"67","author":"LV Syro","year":"2012","unstructured":"Syro LV et al (2012) Pituitary tumors in patients with MEN1 syndrome. Clinics 67(Suppl 1):43\u201348","journal-title":"Clinics"},{"issue":"12","key":"2223_CR73","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1210\/jc.2006-1668","volume":"91","author":"AF Daly","year":"2006","unstructured":"Daly AF et al (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege. Belgium J Clin Endocrinol Metab 91(12):4769\u20134775","journal-title":"Belgium J Clin Endocrinol Metab"},{"issue":"9","key":"2223_CR74","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1210\/JC.2015-2015","volume":"100","author":"JM de Laat","year":"2015","unstructured":"de Laat JM et al (2015) Long-term natural course of pituitary tumors in patients with MEN1: results from the DutchMEN1 study group (DMSG). J Clin Endocrinol Metab 100(9):3288\u20133296","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2223_CR75","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1210\/jc.2014-3659","volume":"100","author":"P Goudet","year":"2015","unstructured":"Goudet P et al (2015) MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d\u2019etude des tumeurs endocrines. J Clin Endocrinol Metab 100(4):1568\u20131577","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2223_CR76","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1007\/s00268-017-3992-9","volume":"41","author":"J Manoharan","year":"2017","unstructured":"Manoharan J et al (2017) Is routine screening of young asymptomatic MEN1 patients necessary? World J Surg 41(8):2026\u20132032","journal-title":"World J Surg"},{"issue":"1","key":"2223_CR77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.surg.2021.04.041","volume":"171","author":"OA Shariq","year":"2022","unstructured":"Shariq OA et al (2022) Multiple endocrine neoplasia type 1 in children and adolescents: clinical features and treatment outcomes. Surgery 171(1):77\u201387","journal-title":"Surgery"},{"issue":"6","key":"2223_CR78","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1210\/jc.2011-2930","volume":"97","author":"L Garby","year":"2012","unstructured":"Garby L et al (2012) Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases. J Clin Endocrinol Metab 97(6):2093\u20132104","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2223_CR79","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ando.2012.09.004","volume":"73","author":"F Borson-Chazot","year":"2012","unstructured":"Borson-Chazot F et al (2012) Acromegaly induced by ectopic secretion of GHRH: a review 30 years after GHRH discovery. Ann Endocrinol 73(6):497\u2013502","journal-title":"Ann Endocrinol"},{"key":"2223_CR80","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-20-0208","author":"V Srirangam Nadhamuni","year":"2021","unstructured":"Srirangam Nadhamuni V et al (2021) GHRH secretion from a pancreatic neuroendocrine tumor causing gigantism in a patient with MEN1. Endocrinol Diabetes Metab Case Rep. https:\/\/doi.org\/10.1530\/EDM-20-0208","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"42","key":"2223_CR81","doi-asserted-by":"publisher","first-page":"15558","DOI":"10.1073\/pnas.0603877103","volume":"103","author":"NS Pellegata","year":"2006","unstructured":"Pellegata NS et al (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 103(42):15558\u201315563","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2223_CR82","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1210\/jc.2019-00082","volume":"104","author":"A Frederiksen","year":"2019","unstructured":"Frederiksen A et al (2019) Clinical features of multiple endocrine neoplasia type 4: novel pathogenic variant and review of published cases. J Clin Endocrinol Metab 104(9):3637\u20133646","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2223_CR83","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1210\/jc.2008-2083","volume":"94","author":"SK Agarwal","year":"2009","unstructured":"Agarwal SK, Mateo CM, Marx SJ (2009) Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. J Clin Endocrinol Metab 94(5):1826\u20131834","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2223_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003350","volume":"9","author":"G Occhi","year":"2013","unstructured":"Occhi G et al (2013) A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype. PLoS Genet 9(3):e1003350","journal-title":"PLoS Genet"},{"issue":"1","key":"2223_CR85","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12020-015-0540-y","volume":"49","author":"S Sambugaro","year":"2015","unstructured":"Sambugaro S et al (2015) Early onset acromegaly associated with a novel deletion in CDKN1B 5\u2019UTR region. Endocrine 49(1):58\u201364","journal-title":"Endocrine"},{"issue":"16","key":"2223_CR86","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.3390\/cancers14163861","volume":"14","author":"M Yamamoto","year":"2022","unstructured":"Yamamoto M, Takahashi Y (2022) Genetic and epigenetic pathogenesis of acromegaly. Cancers 14(16):3861","journal-title":"Cancers"},{"issue":"3","key":"2223_CR87","doi-asserted-by":"publisher","first-page":"e436","DOI":"10.1210\/clinem\/dgaa002","volume":"105","author":"S Espiard","year":"2020","unstructured":"Espiard S et al (2020) Frequency and incidence of carney complex manifestations: a prospective multicenter study with a three-year follow-up. J Clin Endocrinol Metab 105(3):e436","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2223_CR88","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1056\/NEJMc1309730","volume":"370","author":"A Forlino","year":"2014","unstructured":"Forlino A et al (2014) PRKACB and Carney complex. N Engl J Med 370(11):1065\u20131067","journal-title":"N Engl J Med"},{"issue":"1","key":"2223_CR89","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13023-019-1102-9","volume":"14","author":"MK Javaid","year":"2019","unstructured":"Javaid MK et al (2019) Best practice management guidelines for fibrous dysplasia\/McCune-Albright syndrome: a consensus statement from the FD\/MAS international consortium. Orphanet J Rare Dis 14(1):139","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"2223_CR90","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1055\/a-0661-0341","volume":"51","author":"P Xekouki","year":"2019","unstructured":"Xekouki P et al (2019) The 3PAs: an update on the association of pheochromocytomas, paragangliomas, and pituitary tumors. Horm Metab Res 51(7):419\u2013436","journal-title":"Horm Metab Res"},{"issue":"5","key":"2223_CR91","doi-asserted-by":"publisher","first-page":"L37","DOI":"10.1530\/ERC-18-0065","volume":"25","author":"AF Daly","year":"2018","unstructured":"Daly AF et al (2018) Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions. Endocr Relat Cancer 25(5):L37\u2013L42","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"2223_CR92","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.3390\/jcm11082168","volume":"11","author":"F Hannah-Shmouni","year":"2022","unstructured":"Hannah-Shmouni F et al (2022) Neurofibromatosis type 1 Has a wide spectrum of growth hormone excess. J Clin Med 11(8):2168","journal-title":"J Clin Med"},{"issue":"3","key":"2223_CR93","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2265.2009.03717.x","volume":"72","author":"S Williamson","year":"2010","unstructured":"Williamson S, Greene SA (2010) Incidence of thyrotoxicosis in childhood: a national population based study in the UK and Ireland. Clin Endocrinol 72(3):358\u2013363","journal-title":"Clin Endocrinol"},{"issue":"2","key":"2223_CR94","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000430985","volume":"84","author":"R Havgaard Kjaer","year":"2015","unstructured":"Havgaard Kjaer R, Smedegard Andersen M, Hansen D (2015) Increasing incidence of juvenile thyrotoxicosis in denmark: a nationwide study, 1998\u20132012. Horm Res Paediatr 84(2):102\u2013107","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"2223_CR95","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1046\/j.1365-2265.2001.01252.x","volume":"54","author":"GW Wong","year":"2001","unstructured":"Wong GW, Cheng PS (2001) Increasing incidence of childhood Graves\u2019 disease in Hong Kong: a follow-up study. Clin Endocrinol (Oxf) 54(4):547\u2013550","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2223_CR96","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.beem.2018.03.014","volume":"32","author":"J Leger","year":"2018","unstructured":"Leger J, Carel JC (2018) Diagnosis and management of hyperthyroidism from prenatal life to adolescence. Best Pract Res Clin Endocrinol Metab 32(4):373\u2013386","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"10","key":"2223_CR97","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s004310051202","volume":"158","author":"GW Wong","year":"1999","unstructured":"Wong GW, Lai J, Cheng PS (1999) Growth in childhood thyrotoxicosis. Eur J Pediatr 158(10):776\u2013779","journal-title":"Eur J Pediatr"},{"issue":"5","key":"2223_CR98","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/adc.61.5.464","volume":"61","author":"JM Buckler","year":"1986","unstructured":"Buckler JM, Willgerodt H, Keller E (1986) Growth in thyrotoxicosis. Arch Dis Child 61(5):464\u2013471","journal-title":"Arch Dis Child"},{"issue":"5","key":"2223_CR99","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/endo-124-5-2277","volume":"124","author":"MH Samuels","year":"1989","unstructured":"Samuels MH et al (1989) The effect of altered thyroid status on pituitary hormone messenger ribonucleic acid concentrations in the rat. Endocrinology 124(5):2277\u20132282","journal-title":"Endocrinology"},{"issue":"3","key":"2223_CR100","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1365-2265.1983.tb00007.x","volume":"19","author":"SD Chernausek","year":"1983","unstructured":"Chernausek SD et al (1983) Growth hormone secretion and plasma somatomedin-C in primary hypothyroidism. Clin Endocrinol 19(3):337\u2013344","journal-title":"Clin Endocrinol"},{"issue":"3","key":"2223_CR101","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000180644","volume":"25","author":"H Cavaliere","year":"1987","unstructured":"Cavaliere H, Knobel M, Medeiros-Neto G (1987) Effect of thyroid hormone therapy on plasma insulin-like growth factor I levels in normal subjects, hypothyroid patients and endemic cretins. Horm Res 25(3):132\u2013139","journal-title":"Horm Res"},{"issue":"5","key":"2223_CR102","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1365-2265.1993.tb00352.x","volume":"38","author":"M Angervo","year":"1993","unstructured":"Angervo M et al (1993) Thyroxine treatment increases circulating levels of insulin-like growth factor binding protein-1: a placebo-controlled study. Clin Endocrinol 38(5):547\u2013551","journal-title":"Clin Endocrinol"},{"key":"2223_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.653627","volume":"12","author":"TJ Smith","year":"2021","unstructured":"Smith TJ (2021) Insulin-like growth factor pathway and the thyroid. Front Endocrinol 12:653627","journal-title":"Front Endocrinol"},{"issue":"12","key":"2223_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008450","volume":"4","author":"L Aksglaede","year":"2009","unstructured":"Aksglaede L et al (2009) Age at puberty and the emerging obesity epidemic. PLoS ONE 4(12):e8450","journal-title":"PLoS ONE"},{"issue":"4","key":"2223_CR105","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/ijo.2011.238","volume":"36","author":"W Johnson","year":"2012","unstructured":"Johnson W et al (2012) Patterns of linear growth and skeletal maturation from birth to 18 years of age in overweight young adults. Int J Obes 36(4):535\u2013541","journal-title":"Int J Obes"},{"issue":"5","key":"2223_CR106","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ajhb.21191","volume":"23","author":"SD Stovitz","year":"2011","unstructured":"Stovitz SD et al (2011) Growing into obesity: patterns of height growth in those who become normal weight, overweight, or obese as young adults. Am J Hum Biol 23(5):635\u2013641","journal-title":"Am J Hum Biol"},{"issue":"22","key":"2223_CR107","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1056\/NEJM198411293112203","volume":"311","author":"T Williams","year":"1984","unstructured":"Williams T et al (1984) Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med 311(22):1403\u20131407","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"2223_CR108","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mce.2007.12.005","volume":"286","author":"RM Luque","year":"2008","unstructured":"Luque RM, Park S, Kineman RD (2008) Role of endogenous somatostatin in regulating GH output under basal conditions and in response to metabolic extremes. Mol Cell Endocrinol 286(1\u20132):155\u2013168","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2223_CR109","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1210\/jc.2005-2631","volume":"92","author":"N Bouhours-Nouet","year":"2007","unstructured":"Bouhours-Nouet N et al (2007) The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature. J Clin Endocrinol Metab 92(2):629\u2013635","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2223_CR110","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11845-010-0494-2","volume":"179","author":"JF Zhu","year":"2010","unstructured":"Zhu JF et al (2010) Plasma ghrelin levels and polymorphisms of ghrelin gene in Chinese obese children and adolescents. Ir J Med Sci 179(3):345\u2013349","journal-title":"Ir J Med Sci"},{"issue":"4","key":"2223_CR111","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1542\/peds.2005-0085","volume":"115","author":"JM Gomez","year":"2005","unstructured":"Gomez JM, American Academy of Pediatrics Committee on Sports (2005) Use of performance-enhancing substances. Pediatrics 115(4):1103\u20131106","journal-title":"Pediatrics"},{"issue":"1","key":"2223_CR112","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1521-0391.2010.00093.x","volume":"20","author":"BP Brennan","year":"2011","unstructured":"Brennan BP et al (2011) Human growth hormone abuse in male weightlifters. Am J Addict 20(1):9\u201313","journal-title":"Am J Addict"},{"issue":"12","key":"2223_CR113","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1177\/000992289203101206","volume":"31","author":"VI Rickert","year":"1992","unstructured":"Rickert VI et al (1992) Human growth hormone: a new substance of abuse among adolescents? Clin Pediatr 31(12):723\u2013726","journal-title":"Clin Pediatr"},{"issue":"4","key":"2223_CR114","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ghir.2009.04.007","volume":"19","author":"AD Rogol","year":"2009","unstructured":"Rogol AD (2009) Growth hormone and the adolescent athlete: What are the data for its safety and efficacy as an ergogenic agent? Growth Horm IGF Res 19(4):294\u2013299","journal-title":"Growth Horm IGF Res"},{"key":"2223_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.634288","volume":"12","author":"M Spaziani","year":"2021","unstructured":"Spaziani M et al (2021) Clinical, diagnostic, and therapeutic aspects of growth hormone deficiency during the transition period: review of the literature. Front Endocrinol 12:634288","journal-title":"Front Endocrinol"},{"issue":"6","key":"2223_CR116","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1210\/jc.2010-0008","volume":"95","author":"N Guha","year":"2010","unstructured":"Guha N et al (2010) Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport. J Clin Endocrinol Metab 95(6):2969\u20132976","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2223_CR117","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1651-2227.1984.tb09966.x","volume":"73","author":"Z Dickerman","year":"1984","unstructured":"Dickerman Z, Loewinger J, Laron Z (1984) The pattern of growth in children with constitutional tall stature from birth to age 9 years. A longitudinal study. Acta Paediatr Scand 73(4):530\u2013536","journal-title":"Acta Paediatr Scand"},{"issue":"3","key":"2223_CR118","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S2213-8587(15)00380-0","volume":"4","author":"AC Latronico","year":"2016","unstructured":"Latronico AC, Brito VN, Carel JC (2016) Causes, diagnosis, and treatment of central precocious puberty. Lancet Diabetes Endocrinol 4(3):265\u2013274","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2223_CR119","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12995","volume":"33","author":"E Sbardella","year":"2021","unstructured":"Sbardella E et al (2021) A clinical approach to parasellar lesions in the transition age. J Neuroendocrinol 33(6):e12995","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"2223_CR120","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1210\/jcem-67-1-69","volume":"67","author":"AL Barkan","year":"1988","unstructured":"Barkan AL, Beitins IZ, Kelch RP (1988) Plasma insulin-like growth factor-I\/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion. J Clin Endocrinol Metab 67(1):69\u201373","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2223_CR121","first-page":"744","volume":"78","author":"A Juul","year":"1994","unstructured":"Juul A et al (1994) Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78(3):744\u2013752","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2223_CR122","first-page":"20","volume":"51","author":"RW Holl","year":"1999","unstructured":"Holl RW et al (1999) Suppression of growth hormone by oral glucose in the evaluation of tall stature. Horm Res 51(1):20\u201324","journal-title":"Horm Res"},{"issue":"5","key":"2223_CR123","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1515\/jpem-2015-0269","volume":"29","author":"AL Creo","year":"2016","unstructured":"Creo AL, Lteif AN (2016) Pituitary gigantism: a retrospective case series. J Pediatr Endocrinol Metab 29(5):597\u2013602","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"12","key":"2223_CR124","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.3390\/cells11121886","volume":"11","author":"C Selenou","year":"2022","unstructured":"Selenou C et al (2022) IGF2: development, genetic and epigenetic abnormalities. Cells 11(12):1886","journal-title":"Cells"},{"issue":"4","key":"2223_CR125","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1373\/clinchem.2010.150631","volume":"57","author":"DR Clemmons","year":"2011","unstructured":"Clemmons DR (2011) Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem 57(4):555\u2013559","journal-title":"Clin Chem"},{"issue":"6","key":"2223_CR126","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/j.1365-2265.2009.03578.x","volume":"71","author":"N Karavitaki","year":"2009","unstructured":"Karavitaki N et al (2009) The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly. Clin Endocrinol 71(6):840\u2013845","journal-title":"Clin Endocrinol"},{"issue":"1","key":"2223_CR127","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1365-2265.2008.03461.x","volume":"71","author":"M Sherlock","year":"2009","unstructured":"Sherlock M et al (2009) Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly. Clin Endocrinol 71(1):74\u201381","journal-title":"Clin Endocrinol"},{"issue":"12","key":"2223_CR128","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1210\/jcem.84.12.6222","volume":"84","author":"EA Eugster","year":"1999","unstructured":"Eugster EA, Pescovitz OH (1999) Gigantism. J Clin Endocrinol Metab 84(12):4379\u20134384","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2223_CR129","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u20133951","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2223_CR130","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1023\/B:PITU.0000023424.72021.e2","volume":"6","author":"PU Freda","year":"2003","unstructured":"Freda PU et al (2003) Basal and glucose-suppressed GH levels less than 1 microg\/L in newly diagnosed acromegaly. Pituitary 6(4):175\u2013180","journal-title":"Pituitary"},{"issue":"1","key":"2223_CR131","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/MED.0000000000000308","volume":"24","author":"W Bonfig","year":"2017","unstructured":"Bonfig W (2017) Growth and development in children with classic congenital adrenal hyperplasia. Curr Opin Endocrinol Diabetes Obes 24(1):39\u201342","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"8","key":"2223_CR132","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S2213-8587(22)00160-7","volume":"10","author":"R Hamblin","year":"2022","unstructured":"Hamblin R et al (2022) Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance. Lancet Diabetes Endocrinol 10(8):581\u2013588","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9\u201310","key":"2223_CR133","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1159\/000508107","volume":"110","author":"E Sbardella","year":"2020","unstructured":"Sbardella E et al (2020) Late effects of parasellar lesion treatment: hypogonadism and infertility. Neuroendocrinology 110(9\u201310):868\u2013881","journal-title":"Neuroendocrinology"},{"issue":"1","key":"2223_CR134","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/andr.12918","volume":"9","author":"M Tenuta","year":"2021","unstructured":"Tenuta M et al (2021) Somatotropic-testicular axis: a crosstalk between GH\/IGF-I and gonadal hormones during development, transition, and adult age. Andrology 9(1):168\u2013184","journal-title":"Andrology"},{"issue":"1","key":"2223_CR135","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1590\/S0004-27302008000100005","volume":"52","author":"VN Brito","year":"2008","unstructured":"Brito VN et al (2008) Update on the etiology, diagnosis and therapeutic management of sexual precocity. Arq Bras Endocrinol Metabol 52(1):18\u201331","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"2","key":"2223_CR136","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1046\/j.0300-0664.2001.01490.x","volume":"56","author":"CJ Partsch","year":"2002","unstructured":"Partsch CJ, Heger S, Sippell WG (2002) Management and outcome of central precocious puberty. Clin Endocrinol 56(2):129\u2013148","journal-title":"Clin Endocrinol"},{"issue":"3","key":"2223_CR137","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1365-2265.2012.04517.x","volume":"78","author":"AV Freire","year":"2013","unstructured":"Freire AV et al (2013) High diagnostic accuracy of subcutaneous triptorelin test compared with GnRH test for diagnosing central precocious puberty in girls. Clin Endocrinol 78(3):398\u2013404","journal-title":"Clin Endocrinol"},{"issue":"6","key":"2223_CR138","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1365-2265.1995.tb02692.x","volume":"42","author":"A Cavallo","year":"1995","unstructured":"Cavallo A et al (1995) A simplified gonadotrophin-releasing hormone test for precocious puberty. Clin Endocrinol 42(6):641\u2013646","journal-title":"Clin Endocrinol"},{"issue":"12","key":"2223_CR139","first-page":"4536","volume":"84","author":"ML Lawson","year":"1999","unstructured":"Lawson ML, Cohen N (1999) A single sample subcutaneous luteinizing hormone (LH)-releasing hormone (LHRH) stimulation test for monitoring LH suppression in children with central precocious puberty receiving LHRH agonists. J Clin Endocrinol Metab 84(12):4536\u20134540","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2223_CR140","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0022-3476(95)70254-7","volume":"127","author":"EK Neely","year":"1995","unstructured":"Neely EK et al (1995) Normal ranges for immunochemiluminometric gonadotropin assays. J Pediatr 127(1):40\u201346","journal-title":"J Pediatr"},{"issue":"10","key":"2223_CR141","first-page":"3539","volume":"84","author":"VN Brito","year":"1999","unstructured":"Brito VN et al (1999) Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab 84(10):3539\u20133544","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2223_CR142","doi-asserted-by":"publisher","first-page":"e1059","DOI":"10.1542\/peds.2008-1180","volume":"123","author":"CP Houk","year":"2009","unstructured":"Houk CP, Kunselman AR, Lee PA (2009) Adequacy of a single unstimulated luteinizing hormone level to diagnose central precocious puberty in girls. Pediatrics 123(6):e1059\u2013e1063","journal-title":"Pediatrics"},{"issue":"2","key":"2223_CR143","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1530\/EJE-11-0720","volume":"166","author":"Y Pasternak","year":"2012","unstructured":"Pasternak Y et al (2012) The utility of basal serum LH in prediction of central precocious puberty in girls. Eur J Endocrinol 166(2):295\u2013299","journal-title":"Eur J Endocrinol"},{"issue":"22","key":"2223_CR144","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1056\/NEJMcp0800459","volume":"358","author":"JC Carel","year":"2008","unstructured":"Carel JC, Leger J (2008) Clinical practice. Precocious puberty N Engl J Med 358(22):2366\u20132377","journal-title":"Precocious puberty N Engl J Med"},{"issue":"4","key":"2223_CR145","doi-asserted-by":"publisher","first-page":"e752","DOI":"10.1542\/peds.2008-1783","volume":"123","author":"JC Carel","year":"2009","unstructured":"Carel JC et al (2009) Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 123(4):e752\u2013e762","journal-title":"Pediatrics"},{"issue":"4\u20135","key":"2223_CR146","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000185017","volume":"46","author":"C Adamsbaum","year":"1996","unstructured":"Adamsbaum C, Chaussain JL (1996) Diagnostic strategies in pediatric imaging. Horm Res 46(4\u20135):165\u2013169","journal-title":"Horm Res"},{"issue":"5","key":"2223_CR147","first-page":"1295","volume":"13","author":"PM Doraiswamy","year":"1992","unstructured":"Doraiswamy PM et al (1992) MR assessment of pituitary gland morphology in healthy volunteers: age- and gender-related differences. AJNR Am J Neuroradiol 13(5):1295\u20131299","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"2223_CR148","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s00247-005-1512-9","volume":"35","author":"MI Argyropoulou","year":"2005","unstructured":"Argyropoulou MI, Kiortsis DN (2005) MRI of the hypothalamic-pituitary axis in children. Pediatr Radiol 35(11):1045\u20131055","journal-title":"Pediatr Radiol"},{"issue":"2","key":"2223_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2019.05.002","volume":"33","author":"WA Bashari","year":"2019","unstructured":"Bashari WA et al (2019) Modern imaging of pituitary adenomas. Best Pract Res Clin Endocrinol Metab 33(2):101278","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"2223_CR150","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ecl.2016.02.004","volume":"45","author":"JM Bou-Ayache","year":"2016","unstructured":"Bou-Ayache JM, Delman BN (2016) Advances in imaging of the pediatric pituitary gland. Endocrinol Metab Clin North Am 45(2):443\u2013452","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"2223_CR151","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11102-017-0788-8","volume":"20","author":"I Potorac","year":"2017","unstructured":"Potorac I, Beckers A, Bonneville JF (2017) T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective. Pituitary 20(1):116\u2013120","journal-title":"Pituitary"},{"issue":"2","key":"2223_CR152","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s12020-022-03158-w","volume":"78","author":"S Chiloiro","year":"2022","unstructured":"Chiloiro S et al (2022) Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly. Endocrine 78(2):343\u2013353","journal-title":"Endocrine"},{"issue":"2","key":"2223_CR153","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12020-015-0766-8","volume":"52","author":"A Heck","year":"2016","unstructured":"Heck A et al (2016) Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly. Endocrine 52(2):333\u2013343","journal-title":"Endocrine"},{"issue":"1","key":"2223_CR154","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12902-023-01334-1","volume":"23","author":"D De Alcubierre","year":"2023","unstructured":"De Alcubierre D et al (2023) Pituitary adenoma consistency affects postoperative hormone function: a retrospective study. BMC Endocr Disord 23(1):92","journal-title":"BMC Endocr Disord"},{"issue":"7","key":"2223_CR155","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2018-02281","volume":"104","author":"T Feola","year":"2019","unstructured":"Feola T et al (2019) Pegvisomant improves glucose metabolism in acromegaly: a meta-analysis of prospective interventional studies. J Clin Endocrinol Metab 104(7):2892\u20132902","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02223-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02223-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02223-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T22:17:46Z","timestamp":1711491466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02223-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":155,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["2223"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02223-z","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,27]]},"assertion":[{"value":"17 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest relevant to this article to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No approval needed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No patient\/animal was involved in the present research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All Authors give consent for publication.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}